Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Trends in Pharmacological Sciences|February 1, 2003
Agonist induction and conformational selection during activation of a G-protein-coupled receptorLászló Hunyady, Georges Vauquelin, Patrick Vanderheyden
Trends in Pharmacological Sciences|November 5, 2002
Models and methods for studying insurmountable antagonismGeorges Vauquelin, Isabelle Van Liefde, Patrick Vanderheyden
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 15, 2012
Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonismGeorges Vauquelin, Sophie Bostoen, Patrick Vanderheyden, et al.
Neuropharmacology|January 26, 2010
Direct angiotensin II type 2 receptor stimulation decreases dopamine synthesis in the rat striatumBirgit Mertens, Patrick Vanderheyden, Yvette Michotte, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|October 29, 2009
The role of the central renin-angiotensin system in Parkinson's diseaseBirgit Mertens, Patrick Vanderheyden, Yvette Michotte, et al.
CNS Neuroscience & Therapeutics|December 2, 2008
Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsyDimitri De Bundel, Ilse Smolders, Patrick Vanderheyden, et al.
Biochemical Pharmacology|April 16, 2003
A two-state model of antagonist-AT1 receptor interaction: further support by binding studies at low temperatureIlse Verheijen, Jean-Paul De Backer, Patrick Vanderheyden, et al.
Journal of Medicinal Chemistry|September 18, 2009
The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analoguesAneta Lukaszuk, Heidi Demaegdt, Debby Feytens, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|May 4, 2011
Conformational constraints in angiotensin IV to probe the role of Tyr², Pro⁵ and Phe⁶Aneta Lukaszuk, Heidi Demaegdt, Isabelle Van den Eynde, et al.
Pageof 4